Synairgen PLC (GB:SNG)

Synairgen (SNG) Share Price & Analysis


SNG Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range4.00p - 11.00p
Previous Close5.79p
Average Volume (3M)421.52K
Market Cap
Enterprise Value-4.27M
Total Cash (Recent Filing)£15.93M
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)
Sep 26, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding201,345,000
10 Day Avg. Volume2,874,053
30 Day Avg. Volume421,521
Standard Deviation0.68
Financial Highlights & Ratios
Price to Book (P/B)0.73
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0



Options Prices

Currently, No data available

Ownership Overview

0.00% Other Institutional Investors
97.41% Public Companies and
Individual Investors


What was Synairgen PLC’s price range in the past 12 months?
Synairgen PLC lowest share price was 4.00p and its highest was 11.00p in the past 12 months.
    What is Synairgen PLC’s market cap?
    Currently, no data Available
    When is Synairgen PLC’s upcoming earnings report date?
    Synairgen PLC’s upcoming earnings report date is Sep 26, 2024 which is in 101 days.
      How were Synairgen PLC’s earnings last quarter?
      Currently, no data Available
      Is Synairgen PLC overvalued?
      According to Wall Street analysts Synairgen PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Synairgen PLC pay dividends?
        Synairgen PLC does not currently pay dividends.
        What is Synairgen PLC’s EPS estimate?
        Synairgen PLC’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Synairgen PLC have?
        Synairgen PLC has 201,374,970 shares outstanding.
          What happened to Synairgen PLC’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Synairgen PLC?
          Currently, no hedge funds are holding shares in GB:SNG

          Company Description

          Synairgen PLC

          Synairgen PLC is a United Kingdom-based respiratory drug discovery and development company. The company is engaged in the drug discovery and development of therapies for respiratory diseases, particularly in the areas, including severe asthma, kidney fibrosis, cardiac fibrosis, chronic obstructive pulmonary disease, and idiopathic pulmonary fibrosis. The company's Programmes include SNG001, SG016, LOXL2 inhibitor, and others.
          Similar Stocks
          Price & Change
          Futura Medical
          Popular Stocks
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis